Please login to the form below

Not currently logged in
Email:
Password:

MedDay appoints former Sanofi VP to board

Philippe Goupit joins French biotech

Philippe Goupit, MedDayMedDay has strengthened its board with the addition of Sanofi's former VP of corporate licenses.

Philippe Goupit has more than 30 years' experience in the pharma industry, including 20 years at France-based pharma giant Sanofi where he also served as head of corporate mergers and acquisitions and head of investor relations.

MedDay, which was only formed in 2011, will welcome Goupit's knowledge of business development as it looks to expand with its pipeline of drugs for nervous system disorders such as multiple scleroris.

Goupit said: “I strongly believe that MedDay's product pipeline and its research platform, SPECMET, could have a major impact on the treatment of neurological and psychiatric diseases.”

19th January 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics